Dicitore, A.; Gaudenzi, G.; Carra, S.; Cantone, M.C.; Oldani, M.; Saronni, D.; Borghi, M.O.; Grotteschi, J.; Persani, L.; Vitale, G.
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study. Cancers 2023, 15, 5375.
https://doi.org/10.3390/cancers15225375
AMA Style
Dicitore A, Gaudenzi G, Carra S, Cantone MC, Oldani M, Saronni D, Borghi MO, Grotteschi J, Persani L, Vitale G.
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study. Cancers. 2023; 15(22):5375.
https://doi.org/10.3390/cancers15225375
Chicago/Turabian Style
Dicitore, Alessandra, Germano Gaudenzi, Silvia Carra, Maria Celeste Cantone, Monica Oldani, Davide Saronni, Maria Orietta Borghi, Jacopo Grotteschi, Luca Persani, and Giovanni Vitale.
2023. "Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study" Cancers 15, no. 22: 5375.
https://doi.org/10.3390/cancers15225375
APA Style
Dicitore, A., Gaudenzi, G., Carra, S., Cantone, M. C., Oldani, M., Saronni, D., Borghi, M. O., Grotteschi, J., Persani, L., & Vitale, G.
(2023). Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study. Cancers, 15(22), 5375.
https://doi.org/10.3390/cancers15225375